PROTAGENIC THERAPEUTICS INC (PTIX)
US74365N2027 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.00M | -3.56M | -4.52M | -2.55M | -1.75M | |||
| Depreciation Amortization | 28.22K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Change In Working Capital | -114.41K | 540.00K | -140.00K | -360.00K | 700.00K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | 1.38M | 1.02M | 1.86M | 1.56M | 560.00K | |||
| OPERATING CASH FLOW | -3.70M | -1.99M | -2.80M | -1.35M | -490.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -149.78K | 0.00 | N/A | N/A | N/A | |||
| Other Investing Activity | 4.93M | 1.60M | -9.91M | 0.00 | 250.00K | |||
| INVESTING CASH FLOW | 4.78M | 1.60M | -9.91M | 0.00 | 250.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | 1.33M | 670.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 12.58M | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | -100.00K | N/A | |||
| FINANCING CASH FLOW | N/A | 0.00 | 12.58M | 1.22M | 670.00K | |||
| Exchange Rate Effect | 1.00K | 70.00K | 0.00 | 0.00 | 0.00 | |||
| CHANGE IN CASH | 1.07M | -320.00K | -130.00K | -130.00K | 430.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.70M | -1.99M | -2.80M | -1.35M | -490.00K | |||
| Capital Expenditure | -149.78K | 0.00 | N/A | N/A | N/A | |||
| FREE CASH FLOW | -3.85M | -1.99M | -2.80M | -1.35M | -490.00K | |||
All data in USD